These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37082120)

  • 1. Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy.
    Zhou L; Qu H; Zhang Q; Hu J; Shou L
    Front Endocrinol (Lausanne); 2023; 14():1168927. PubMed ID: 37082120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review.
    Huang L; Liang M; He Y
    J Korean Med Sci; 2023 Jun; 38(24):e209. PubMed ID: 37337812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection.
    Murakawa K; Aasi H; Sato K; Yoshioka S; Sho H; Inui R; Kosugi M; Hazama Y; Yasuda T
    Diabetol Int; 2024 Jul; 15(3):621-626. PubMed ID: 39101178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report.
    Sasaki K; Morioka T; Okada N; Natsuki Y; Kakutani Y; Ochi A; Yamazaki Y; Shoji T; Ohmura T; Emoto M
    J Diabetes Investig; 2022 Jul; 13(7):1286-1289. PubMed ID: 35167186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection as possible downstream disease precipitator in autoantibody-positive insulin-dependent diabetes mellitus: a case report.
    Schiaffini R; Campana A; Deodati A; Peschiaroli E; Lanzillotta MF; Fierabracci A
    Ital J Pediatr; 2022 Feb; 48(1):33. PubMed ID: 35197086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report.
    Lin R; Lin YW; Chen MH
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report.
    Hollstein T; Schulte DM; Schulz J; Glück A; Ziegler AG; Bonifacio E; Wendorff M; Franke A; Schreiber S; Bornstein SR; Laudes M
    Nat Metab; 2020 Oct; 2(10):1021-1024. PubMed ID: 32879473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes recurrence after SARS-CoV-2 infection in a subject with pancreas transplantation.
    Popolla V; Rizzi A; Tartaglione L; Pontecorvi A; Pitocco D
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e364. PubMed ID: 36307982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic.
    Sano H; Imagawa A
    Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36421377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
    Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
    Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection.
    Wang J; Huang Y; Tao F
    Heliyon; 2024 May; 10(9):e30750. PubMed ID: 38756607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection.
    Anindya R; Rutter GA; Meur G
    Immunol Cell Biol; 2023 Mar; 101(3):191-203. PubMed ID: 36529987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination.
    Izumi T; Takahashi H; Takahashi H
    Diabetol Int; 2023 Oct; 14(4):422-426. PubMed ID: 37781472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral.
    Kusuki K; Suzuki S; Mizuno Y
    Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome.
    Kim HS; Lee TY; Kim EY; Choi JH; Kim SY; Hwang YC; Kang JH; Ahn KJ; Chung HY; Jeong IK
    Diabet Med; 2012 Oct; 29(10):1335-8. PubMed ID: 22356444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant type 1 diabetes mellitus in a GDM pregnancy: early recognition is vital for maternal and fetal outcomes.
    Choy KHA; Wong T; Cao RHM; Flack JR
    Endocrinol Diabetes Metab Case Rep; 2022 Jul; 2022():. PubMed ID: 35899692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis and COVID-19: what have we learned so far?
    de Sá-Ferreira CO; da Costa CHM; Guimarães JCW; Sampaio NS; Silva LML; de Mascarenhas LP; Rodrigues NG; Dos Santos TL; Campos S; Young EC
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E44-E53. PubMed ID: 34779657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps.
    Wallia A; Prince G; Touma E; El Muayed M; Seley JJ
    Curr Diab Rep; 2020 Nov; 20(12):77. PubMed ID: 33244614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.